Palvella Therapeutics News and Activities

Palvella Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Palvella Therapeutics is a company listed under the stock ticker PVLA (US).

View the org chart displaying its 25 main executives

Most searched biographies at Palvella Therapeutics

• Wes Kaupinen, President, Chief Executive Officer and Director
• John Doux, Director
• Chris Kiritsy, Director

Popular executive movements at Palvella Therapeutics

• John Doux has joined the company as Director  (posted on April 13 2026).
• Kent Taylor has joined the company as Senior Vice President of Sales  (posted on April 7 2026).
• Jennifer McDonough has joined the company as Senior Vice President of Market Access and Patient Services  (posted on March 23 2026).

Click here to view some more movements at Palvella Therapeutics

Create your alert
to follow the executive moves at Palvella Therapeutics.

Palvella Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Palvella Therapeutics

• Press Releases | Palvella Therapeutics
• Advocacy / Partnerships - Palvella Therapeutics
• Investors - Palvella Therapeutics
• Press Releases - Palvella Therapeutics

Social media about Palvella Therapeutics

• Palvella Therapeutics on Wikipedia, Google News & Yahoo Finance
• Palvella Therapeutics on LinkedIn, X (Twitter) & YouTube